Related Experiment Video
Updated: Aug 5, 2026

09:06
Spatially Resolved, Integrated Single-Cell Multiomic Profiling of the Transcriptome and Epigenomic Targets in Frozen Tissue Sections
Published on: June 12, 2026
Spatial transcriptomic analysis reveals spatial features in human Stanford type A aortic dissection
Yan-Hong Li1, Ying Cao2, Fen Liu3,4
1Clinical Laboratory, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China.
Iscience
|July 28, 2026
Summary
Stanford type A aortic dissection (AAD) involves aortic wall tearing. SPP1-driven inflammation intensifies with AAD severity, revealing a nine-gene scale and collagen remodeling signatures for biomarker discovery and targeted therapies.
Area of Science:
- Cardiovascular Biology
- Molecular Pathology
- Genomics
Background:
- Stanford type A aortic dissection (AAD) is a critical cardiovascular condition.
- AAD involves a tear in the aortic wall, posing a significant health risk.
Purpose of the Study:
- To comprehensively analyze molecular changes in ascending aortas from AAD patients.
- To identify molecular signatures associated with AAD severity and progression.
- To explore potential biomarkers and therapeutic targets for AAD.
Main Methods:
- Spatial transcriptomics and multiplex immunofluorescence were employed.
- Ascending aortas from eight AAD patients of varying severities and segments were analyzed.
- Gene expression patterns and protein markers were investigated.
Main Results:
- SPP1-driven inflammatory signaling was found to intensify with increasing AAD severity.
- A nine-gene severity scale (MYL6/CALD1/MYH9 for mild, CCL2/CP/COL4A1 for moderate, TMSB4X/ATP5F1E/PKM for severe) was identified.
- A collagen-remodeling gene triad (COL1A1/COL3A1/MMP2) was upregulated in specific arteries, potentially preceding ascending aortic changes.
Conclusions:
- Molecular signatures, including the SPP1-inflammatory axis and collagen remodeling, offer insights into AAD mechanisms.
- These findings support the development of non-invasive biomarkers for risk stratification.
- The identified molecular pathways present targets for precision pharmacotherapy in AAD treatment.
